IPXL

Impax Laboratories, Inc. News Headlines

$40.29
*  
0.41
1.01%
Get IPXL Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading IPXL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    IPXL After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
2/20/2015 9:00:00 AM - Seeking Alpha


Adamas' Lead Drug Targets Parkinson's Dyskinesia
2/3/2015 5:53:00 PM - Seeking Alpha


Teva Gains FDA Nod for Generic of AstraZeneca's Nexium - Analyst Blog
1/28/2015 6:10:00 AM - Investopedia


Actavis to Buy Auden Mckenzie, Boost Generic Portfolio - Analyst Blog
1/27/2015 6:00:00 AM - Investopedia


PFE Cuts Vaccine Price, CVM On Track, BABY Takes New Step, IPXL On A High
1/27/2015 4:42:00 AM - RTT News


New Drug Approvals - The Month That Was
1/26/2015 10:27:00 AM - RTT News


Impax: FDA Approves Generic Lamictal ODT Antiepileptic Drug - Quick Facts
1/26/2015 8:20:00 AM - RTT News


Supernus Files Oxtellar XR Patent Infringement Lawsuit Again - Analyst Blog
1/26/2015 4:00:00 AM - Investopedia


Bayer Announces Updates to European Label of Xarelto - Analyst Blog
1/21/2015 6:17:00 AM - Investopedia


Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog
1/21/2015 6:13:00 AM - Investopedia


Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog
1/21/2015 6:08:00 AM - Investopedia


Teva Up on Positive Copaxone Supreme Court Ruling - Analyst Blog
1/21/2015 4:00:00 AM - Investopedia


Actavis/Gedeon Richter Present Schizophrenia Drug Data - Analyst Blog
1/20/2015 4:30:00 AM - Investopedia


Actavis' Q4 Earnings to Beat Expectations, Growth Continues - Analyst Blog
1/13/2015 4:00:00 AM - Investopedia


Update: Impax Laboratories' Reversal Of Misfortune
1/10/2015 8:07:00 AM - Seeking Alpha


Impax Soars on FDA Nod of Parkinson's Disease Drug Rytary - Analyst Blog
1/9/2015 4:39:00 AM - Investopedia


Impax Laboratories Inc. (IPXL) Has Broken Out To A New High After FDA Approval
1/8/2015 9:40:00 AM - RTT News


Impax Wins FDA Nod For RYTARY ER Capsules For Treatment Of Parkinson''s Disease
1/8/2015 8:18:00 AM - RTT News


NeuroDerm Skyrockets on Parkinson's Disease Study Data - Analyst Blog
12/31/2014 3:50:00 AM - Investopedia


An Upcoming Catalyst At Impax Laboratories
12/18/2014 11:57:00 AM - Seeking Alpha


Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog
12/16/2014 6:20:00 AM - Investopedia


Genervon ALS drug shows encouraging results
10/20/2014 8:27:00 AM - Seeking Alpha


The Characteristics Of High-Return Stocks
8/8/2014 7:25:00 AM - Seeking Alpha


Today In SA PRO: Monday, June 23
6/24/2014 5:00:00 AM - Seeking Alpha


6 Stocks With High Days-To-Cover Ratios That Could Trap The Bears
6/10/2014 4:49:00 AM - Seeking Alpha